Quantia Ige
Ige, Antigen, Antiserum, Control. 510(k) K050493, from Biokit, S.A. (Barcelona, ES). Product code DGC, class 2.
As of Nov 22, 2026, K050493 is an FDA 510(k) held by Biokit, S.A., substantially equivalent on Aug 16, 2005 after 169 days, with no recalls tied to it in FDA's recall database.
- Review time: 169 days
- Recalls: 0
- Cited as a predicate by: 1 device
Quantia IgE is intended as a latex particle enhanced immunoturbidimetric assay for the in vitro quantitative determination of Immunoglobulin E concentration in human serum or plasma (EDTA, heparin, citrate) on the AEROSET System. Measurement of IgE is useful in the clinical diagnosis of IgE-mediated allergies, if used in conjunction with other clinical studies.
- Unicap Total Ige Assay/Pharmacia Total Ige Controls LmhK964152 · Pharmacia, Inc. · Apr 23, 1997
- Quantia IgEK214068 · Biokit, S.A. · Feb 21, 2023
- Quantia IgEK214068 · Biokit, S.A. · Feb 21, 2023
- Total Immunoglobulin E (IgE)K220178 · Beckman Coulter, Inc. · Mar 23, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 28, 2005
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5510
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files